Clinical Trials Directory

Trials / Completed

CompletedNCT00100464

Serotonin and the Upper Airway in Obstructive Sleep Apnea

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
16 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if a certain medication, alone or combined with another medication, will increase muscle activity in the upper airway in people who do and people who do not have sleep apnea. The medications being studied are paroxetine, a commonly used antidepressant, and 5 hydroxy-tryptophan (5HTP), which also can be used as a dietary supplement without a prescription. Because the effects of paroxetine in previous studies were not very large, we will also study it combined with 5HTP to see if the effect on the upper airway muscles is greater.

Conditions

Interventions

TypeNameDescription
DRUGParoxetine
DRUG5HTP

Timeline

Start date
2000-11-01
Primary completion
2003-12-01
Completion
2003-12-01
First posted
2004-12-31
Last updated
2013-09-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00100464. Inclusion in this directory is not an endorsement.